Trxade Group (MEDS) just unveiled an announcement.
TRxADE Health, Inc. has welcomed Subbarao Jayanthi to its Board of Directors, bringing a wealth of experience from his current role as Managing Partner at RxC International and board positions in biopharma companies. With a background in advising on corporate strategy and a history of leadership in global consulting firms, Mr. Jayanthi’s expertise is set to be a valuable asset to TRxADE. His appointment coincides with Narasimhan Mani’s departure from the board, which was amicable and without controversy.
See more data about MEDS stock on TipRanks’ Stock Analysis page.
